126 related articles for article (PubMed ID: 34565365)
1. ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells.
Chen H; Ye Z; Xu X; Qin Y; Song C; Fan G; Hu H; Hu Y; Yu X; Liu W; Ji S; Xu W
Cancer Cell Int; 2021 Sep; 21(1):514. PubMed ID: 34565365
[TBL] [Abstract][Full Text] [Related]
2. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
3. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
[TBL] [Abstract][Full Text] [Related]
4. High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma.
Tang Y; Yang X; Feng K; Hu C; Li S
J Gastrointest Oncol; 2021 Feb; 12(1):174-183. PubMed ID: 33708434
[TBL] [Abstract][Full Text] [Related]
5. The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation.
Kuang Q; Liang Y; Zhuo Y; Cai Z; Jiang F; Xie J; Zheng Y; Zhong W
Onco Targets Ther; 2021; 14():3353-3366. PubMed ID: 34079281
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
7. Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors.
Zhang F; Lin JD; Zuo XY; Zhuang YX; Hong CQ; Zhang GJ; Cui XJ; Cui YK
BioData Min; 2017; 10():6. PubMed ID: 28191039
[TBL] [Abstract][Full Text] [Related]
8. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest.
Morii M; Fukumoto Y; Kubota S; Yamaguchi N; Nakayama Y; Yamaguchi N
Cell Biol Int; 2015 Aug; 39(8):923-32. PubMed ID: 25790472
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
10. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells.
Cui C; Huo Q; Xiong X; Li K; Fishel ML; Li B; Yokota H
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896207
[TBL] [Abstract][Full Text] [Related]
12. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
13. Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.
Gu M; Jiang B; Li H; Zhu D; Jiang Y; Xu W
Am J Transl Res; 2022; 14(9):6586-6595. PubMed ID: 36247245
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.
Zou J; Zhang D; Qin G; Chen X; Wang H; Zhang D
Cell Cycle; 2014; 13(23):3685-97. PubMed ID: 25483079
[TBL] [Abstract][Full Text] [Related]
15. A novel ATM-dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma.
Spoerri L; Brooks K; Chia K; Grossman G; Ellis JJ; Dahmer-Heath M; Škalamera D; Pavey S; Burmeister B; Gabrielli B
Pigment Cell Melanoma Res; 2016 May; 29(3):329-39. PubMed ID: 26854966
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process.
Rodríguez A; Torres L; Juárez U; Sosa D; Azpeitia E; García-de Teresa B; Cortés E; Ortíz R; Salazar AM; Ostrosky-Wegman P; Mendoza L; Frías S
Theor Biol Med Model; 2015 Sep; 12():19. PubMed ID: 26385365
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours.
Fernando M; Duijf PHG; Proctor M; Stevenson AJ; Ehmann A; Vora S; Skalamera D; Adams M; Gabrielli B
Oncogenesis; 2021 May; 10(5):41. PubMed ID: 33993200
[TBL] [Abstract][Full Text] [Related]
19. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
20. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
